A New Risk Chart for Acute Myocardial Infarction by a Innovative Algoritm

Acute myocardial infarction (AMI) is complex disease; its pathogenesis is not completely understood and several variables are involved in the disease.. The aim of this paper was to assess: 1) the predictive capacity of Artificial Neural Networks (ANNs) in consistently distinguishing the two different conditions (AMI or control). 2) the identification of those variables with the maximal relevance for AMI. Genetic variances in inflammatory genes and clinical and classical risk factors in 149 AMI patients and 72 controls were investigated. From the data base of this case/control study 36 variables were selected. TWIST system, an evolutionary algorithm able to remove redundant and noisy information from complex data sets, selected 18 variables. Fitness, sensitivity, specificity, overall accuracy of the association of these variables with AMI risk were investigated. Our findings showed that ANNs are useful in distinguishing risk factors selectively associated with the disease. Finally, the new variable cluster, including classical and genetic risk factors, generated a new risk chart able to discriminate AMI from controls with an accuracy of 90%. This approach may be used to assess individual AMI risk in unaffected subjects with increased risk of the disease such as first relative with positive parental history of AMI.

[1]  Paolo Massimo Buscema,et al.  An optimized experimental protocol based on neuro-evolutionary algorithms: Application to the classification of dyspeptic patients and to the prediction of the effectiveness of their treatment , 2005, Artif. Intell. Medicine.

[2]  S. Yusuf,et al.  Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. , 2001, Circulation.

[3]  C Babiloni,et al.  The I.F.A.S.T. model allows the prediction of conversion to Alzheimer disease in patients with mild cognitive impairment with high degree of accuracy. , 2010, Current Alzheimer research.

[4]  E. Corder,et al.  Sharing pathogenetic mechanisms between acute myocardial infarction and Alzheimer's disease as shown by partially overlapping of gene variant profiles. , 2011, Journal of Alzheimer's disease : JAD.

[5]  D. Cucinotta,et al.  Conselice study: a population based survey of brain aging in a muncipality of the Emilia Romagna region: (A.U.S.L. Ravenna). Design and methods. , 2001, Archives of gerontology and geriatrics. Supplement.

[6]  M Buscema,et al.  Assessment of the Role of Genetic Polymorphism in Venous Thrombosis Through Artificial Neural Networks , 2005, Annals of human genetics.

[7]  M. Pfeffer,et al.  Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. , 2000, Circulation.

[8]  M. Buscema,et al.  A Novel Mathematical Approach to Define the Genes/SNPs Conferring Risk or Protection in Sporadic Amyotrophic Lateral Sclerosis Based on Auto Contractive Map Neural Networks and Graph Theory , 2012, Neurology research international.

[9]  James L. McClelland,et al.  An interactive activation model of context effects in letter perception: Part 2. The contextual enhancement effect and some tests and extensions of the model. , 1982, Psychological review.

[10]  Massimo Buscema,et al.  Artificial neural networks identify the predictive values of risk factors on the conversion of amnestic mild cognitive impairment. , 2010, Journal of Alzheimer's disease : JAD.

[11]  Massimo Buscema,et al.  Artificial neural networks in the recognition of the presence of thyroid disease in patients with atrophic body gastritis. , 2008, World journal of gastroenterology.

[12]  Massimo Buscema,et al.  Training with Input Selection and Testing (TWIST) Algorithm: A Significant Advance in Pattern Recognition Performance of Machine Learning , 2013 .

[13]  Paolo Massimo Buscema,et al.  Genetic doping algorithm (GenD): theory and applications , 2004, Expert Syst. J. Knowl. Eng..

[14]  S. Ye,et al.  Genetic determinants of coronary heart disease: new discoveries and insights from genome-wide association studies , 2011, Heart.

[15]  E. Falk,et al.  Traditional SCORE-based health check fails to identify individuals who develop acute myocardial infarction. , 2013, Danish medical journal.

[16]  Iftikhar J Kullo,et al.  Mechanisms of Disease: the genetic basis of coronary heart disease , 2007, Nature Clinical Practice Cardiovascular Medicine.

[17]  M. Buscema,et al.  Gene-gene and gene - clinical factors interaction in acute myocardial infarction: a new detailed risk chart. , 2010, Current pharmaceutical design.

[18]  Paolo Massimo Buscema,et al.  New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background , 2008, BMC Bioinformatics.

[19]  Massimo Buscema,et al.  Artificial neural networks accurately predict mortality in patients with nonvariceal upper GI bleeding. , 2011, Gastrointestinal endoscopy.

[20]  R. Tibshirani,et al.  Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts , 2012, Current medical research and opinion.

[21]  Massimo Buscema,et al.  Appropriateness Guidelines and Predictive Rules to Select Patients for Upper Endoscopy: A Nationwide Multicenter Study , 2009, The American Journal of Gastroenterology.

[22]  M Buscema,et al.  International experience on the use of artificial neural networks in gastroenterology. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[23]  H. Griffiths,et al.  The role of monocytes in atherosclerotic coronary artery disease , 2010, Annals of medicine.

[24]  A. Mainous,et al.  Combining serum biomarkers: the association of C-reactive protein, insulin sensitivity, and homocysteine with cardiovascular disease history in the general US population , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[25]  D. Latorra,et al.  Enhanced allele‐specific PCR discrimination in SNP genotyping using 3′ locked nucleic acid (LNA) primers , 2003, Human mutation.

[26]  R. Della Bona,et al.  Inflammatory biomarkers and coronary heart disease: from bench to bedside and back , 2010, Internal and emergency medicine.

[27]  PhD Cuihua Zhang MD The role of inflammatory cytokines in endothelial dysfunction , 2008, Basic Research in Cardiology.

[28]  Enzo Grossi,et al.  Polymorphisms in folate-metabolizing genes, chromosome damage, and risk of Down syndrome in Italian women: identification of key factors using artificial neural networks , 2010, BMC Medical Genomics.

[29]  Enzo Grossi,et al.  Placental determinants of fetal growth: identification of key factors in the insulin-like growth factor and cytokine systems using artificial neural networks , 2008, BMC pediatrics.

[30]  Peter Libby,et al.  Inflammation in Atherosclerosis : From Vascular Biology to Biomarker Discovery and Risk Prediction , 2007 .

[31]  A. Hamsten,et al.  Identifying the susceptibility genes for coronary artery disease: from hyperbole through doubt to cautious optimism , 2008, Journal of internal medicine.

[32]  M. Franceschi,et al.  Tower of London Test: A Comparison between Conventional Statistic Approach and Modelling Based on Artificial Neural Network in Differentiating Fronto-Temporal Dementia from Alzheimer’s Disease , 2011, Behavioural neurology.

[33]  M. Buscema,et al.  Application of Artificial Neural Networks to Investigate One-Carbon Metabolism in Alzheimer’s Disease and Healthy Matched Individuals , 2013, PloS one.

[34]  Association of early‐onset Alzheimer's disease with an interleukin‐1α gene polymorphism , 2000, Annals of neurology.

[35]  Paulo J. G. Lisboa,et al.  A review of evidence of health benefit from artificial neural networks in medical intervention , 2002, Neural Networks.

[36]  Sergio Callegari,et al.  Pro-inflammatory genetic profile and familiarity of acute myocardial infarction , 2012, Immunity & Ageing.

[37]  C. Jerjes-Sánchez,et al.  Risk Factors, Therapeutic Approaches, and In‐Hospital Outcomes in Mexicans With ST‐Elevation Acute Myocardial Infarction: The RENASICA II Multicenter Registry , 2013, Clinical cardiology.

[38]  E. Porcellini,et al.  Interleukin‐6 gene polymorphism is an age‐dependent risk factor for myocardial infarction in men , 2005, International journal of immunogenetics.

[39]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[40]  Enzo Grossi,et al.  Is it possible to clinically differentiate erosive from nonerosive reflux disease patients? A study using an artificial neural networks-assisted algorithm , 2010, European journal of gastroenterology & hepatology.

[41]  F Levi,et al.  Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world , 2002, Heart.

[42]  John Andersson,et al.  Adaptive immunity and atherosclerosis. , 2010, Clinical immunology.

[43]  R. Kaaks,et al.  Primary preventive potential of major lifestyle risk factors for acute myocardial infarction in men: an analysis of the EPIC-Heidelberg cohort , 2014, European Journal of Epidemiology.